Table 2.
Clinical characteristics of TCGA-ICC and GEO-ICC samples in this study.
| Variables | Training group | Testing group |
|---|---|---|
| (N = 33) | (N = 30) | |
| Age(Mean±SD) | — | 65.60 ± 8.74 |
| Follow-up(y) | 1.99 ± 1.51 | 2.32 ± 1.74 |
| Status | ||
| Alive | 18 (54.55) | 13 (43.33) |
| Dead | 15 (45.45) | 17 (56.67) |
| Gender | ||
| Male | 14 (42.42) | 24 (80.00) |
| Female | 19 (57.58) | 6 (20.00) |
| Stage | ||
| I | 18 (54.55) | 15 (50.00) |
| II | 9 (27.27) | 6 (20.00) |
| III | 1 (3.03) | 1 (3.33) |
| IV | 5 (15.15) | 8 (26.67) |
| AJCC-T | ||
| T1 | 18 (54.55) | — |
| T2 | 10 (30.30) | — |
| T3 | 5 (15.15) | — |
| T4 | 0 | — |
| Risk-score levels | ||
| High | 16 (48.48) | 18 (60.00) |
| low | 17 (51.52) | 12 (40.00) |